Loss of Expression of a Retro virus-Transduced Gene in Human Keratinocytes

Journal of Investigative Dermatology

Volumn 106, Issue 3, 1996, Pages 576-578

  Fenjves, Elizabeth S ^a   Yao, Shou Nan ^b   Kurachi, Kotoku ^b   Taichman, Lorne B ^a  

^a STONY BROOK UNIVERSITY   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Factor IX; Gene therapy

Indexed keywords

BLOOD CLOTTING FACTOR 9; VIRUS VECTOR;

ARTICLE; CONTROLLED STUDY; GENE THERAPY; GENETIC TRANSDUCTION; HUMAN; HUMAN CELL; KERATINOCYTE; MALE; MOLECULAR BIOLOGY; NEWBORN; NORMAL HUMAN; PRIORITY JOURNAL; RETROVIRUS;

ANIMALS; APOLIPOPROTEINS E; CELLS, CULTURED; FACTOR IX; GENE EXPRESSION; GENE THERAPY; HUMANS; KERATINOCYTES; MICE; MICE, NUDE; PROTEIN PRECURSORS; RETROVIRIDAE; TIME FACTORS; TRANSDUCTION, GENETIC; TRANSPLANTATION, HETEROLOGOUS;

EID: 0029918009     PISSN: 0022202X     EISSN: None     Source Type: Journal    
DOI: 10.1111/1523-1747.ep12344976     Document Type: Article

References (25)

1. Carroll JM, Fenjves ES, Garlick JA, Taithman LB: Keratinocytes as a target for gene therapy. In: Darmon M. Blumenberg M (eds). Molecular Biology of the Skin. Academic Press, San Diego, 1993, pp 269-284
2. Challita P-M, Kohn DB: Lack of expression from a retroviral vector after transduction of murine hematopoietic stem cells is associated with methylation in vivo. Proc Natl Acad Sci U S A 91:2567-2571, 1994
3. Dai Y, Roman M, Naviaux RK, Verma IM: Gene therapy via primary myoblasts: long-term expression of factor IX protein following transplantation in vivo. Proc Natl Acad Sci U S A 89:10892-10895, 1992
4. Danos O, Mulligan RC: Safe and efficient generation of recombinant retroviruses wich amphotropic and ecotropic host ranges. Proc Natl Acad Sci U S A 85:6460-6464, 1988
5. Fenjves ES: Approaches to gene transfer in keratinocytes. J Invest Dermatol 103:70S-75S, 1994
6. Fenjves ES, Gordon DA, Pershing LK, Williams DL, Taichman LB: Systemic distribution of apolipoprotein E secreted by grafts of epidermal keratinocytes: implications for epidermal function and gene therapy. Proc Natl Acad Sci U S A 86:8803-8807, 1989
7. Fenjves ES, Smith J, Zaradic S, Taichman LB: Systemic delivery of secreted protein by grafts of epidermal keratinocytes: prospects for keratinocyte gene therapy. Hum Gene Ther 5: 1241-1248, 1994
8. Flowers MED, Stockschlaeder MAR, Schuening FG, Niederwieser D, Hackman R, Miller AD, Storb R: Long-term transplantation of canine keratinocytes made resistant to G418 through retrovirus-mediated gene transfer. Proc Natl Acad Sci U S A 87:2349-2353, 1990
9. Garlick JA, Katz AB, Fenjves ES, Taichman LB: Retrovirus-mediated transduction of cultured epidermal keratinocytes. J Invest Dermatol 97:824-829, 1991
10. Gerrard AJ, Austen DEG, Brownlee GG: Subcutaneous injection of factor IX for the treatment of haemophilia B. Br J Haematol 81:610-613, 1992
11. Gerrard AJ, Hudson DL, Brownlee GG, Watt FM: Towards gene therapy for haemophilia B using primary human keratinocytes. Nat Genet 3:180-183, 1993
12. Gordon DA, Fenjves ES, Williams DL, Taichman LB: Synthesis and secretion of apolipoprotein E by cultured human keratinocytes. J Dermatol 92:96-99, 1989
13. Green H, Kehinde O, Thomas J: Growth of cultured human epidermal cells into multiple epithelia suitable for grafting. Proc. Natl Acad Sci U S A 76:5665-5668, 1979
14. Hafenrichter DG, Wu X, Rettinger SD, Kennedy SC, Flye MW, Ponder KP: Quantitative evaluation of liver-specific promoters from retroviral vectors after in vivo transduction of hepatocytes. Blood 84:3394-3404, 1994
15. Heartlein MW, Roman VA, Jiang J, Sellers JW, Zuliani AM, Treco DA, Selden RF: Long-term production and delivery of human growth hormone in vivo. Proc Natl Acad Sci U S A 91:10967-10971, 1994
16. Kaleko M, Garcia JV, Osborne WRA, Miller AD: Expression of human adenosine deaminase in mice after transplantation of genetically-modified bone marrow. Blood 75:1733-1741, 1990
17. Miller AD, Miller DG, Garcia JV, Lynch CM: Use of retroviral vectors for gene transfer and expression. Methods Enzymol 217:581-599, 1993
18. Naffakh N, Henri A, Villeval JL, Rouyer-Fessard P, Moullier P, Blumenfeld N, Danos O, Vainchenker W, Heard JM, Beuzard Y: Sustained delivery of erythropoietin in mice by genetically modified skin fibroblasts. Proc Natl Acad Sci U S A 92:3194-3198, 1995
19. Palmer TD, Rosman GL, Osborne WRA, Miller AD: Genetically modified skin fibroblasts persist long after transplantation but gradually inactivate introduced genes. Proc Natl Acad Sci U S A 88:1330-1334, 1991
20. Rheinwald JG, Green H: Serial cultivation of strains of human epidermal keratinocytes; the formation of keratinocyte colonies from single cells. Cell 6:331-344, 1975
21. Scharfinann R, Axelrod JH, Verma IM: Long-term in vivo expression of retrovirus-mediated gene transfer in mouse fibroblast implants. Proc Natl Acad Sci U S A 88:4626-4630, 1991
22. Stockschlader MAR, Schuening FG, Graham TC, Storb R: Transplantation of retrovirus-transduced canine keratinocytes expressing the β-galactosidase gene. Gene Ther 1:317-322, 1994
23. Strauss M: Liver-directed gene therapy: prospects and problems, Gene Ther 1:156-164, 1994
24. Yao S, Smith KJ, Kurachi K: Primary myoblast-mediated gene transfer: persistent expression of human factor IX in mite. Gene Ther 1:99-109, 1994
25. Yao S, Wilson JM, Nabel EG, Kurachi S, Hachiya HI, Kurachi K: Expression of human factor IX in rat capillary endothelial cells: toward somatic gene therapy for hemophilia B. Proc Natl Acad Sci U S A 88:8101-8105, 1991